NARGIZA VOLAKOS: Open Payments
NPI 1912366808 · STATEN ISLAND, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,904 in 187 payments from 21 companies in 2025. Trend: 2023 $1,596 · 2024 $3,637 · 2025 $5,904
Food & beverage: $5,904
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 19 | $953 |
| Incyte Corporation | 22 | $880 |
| Galderma Laboratories, L.P. | 17 | $519 |
| LEO Pharma Inc. | 9 | $423 |
| ABBVIE INC. | 11 | $410 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 14 | $400 |
| UCB, Inc. | 16 | $371 |
| GENZYME CORPORATION | 5 | $312 |
| Novartis Pharmaceuticals Corporation | 17 | $302 |
| Amgen Inc. | 11 | $270 |
Products named: Zoryve, OPZELURA, DUPIXENT, NEMLUVIO, Bimzelx, ILUMYA, OTEZLA, TREMFYA.
Industry payments across NY — which companies pay providers there.
